MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 140 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,076,000 | -92.3% | 30,517 | -90.8% | 0.02% | -91.5% |
| Q4 2021 | $13,888,000 | -27.9% | 331,463 | -15.5% | 0.20% | -36.6% |
| Q3 2021 | $19,257,000 | +1.9% | 392,361 | -13.4% | 0.31% | -10.8% |
| Q2 2021 | $18,901,000 | +3.2% | 452,944 | -11.9% | 0.35% | -13.3% |
| Q1 2021 | $18,317,000 | +5.5% | 513,957 | -17.0% | 0.41% | -11.9% |
| Q4 2020 | $17,369,000 | – | 619,217 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |